181 related articles for article (PubMed ID: 12793594)
1. The relationship of obesity to the metabolic syndrome.
Lebovitz HE
Int J Clin Pract Suppl; 2003 Mar; (134):18-27. PubMed ID: 12793594
[TBL] [Abstract][Full Text] [Related]
2. Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle.
He W; Barak Y; Hevener A; Olson P; Liao D; Le J; Nelson M; Ong E; Olefsky JM; Evans RM
Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15712-7. PubMed ID: 14660788
[TBL] [Abstract][Full Text] [Related]
3. Thiazolidinediones--tools for the research of metabolic syndrome X.
Komers R; Vrána A
Physiol Res; 1998; 47(4):215-25. PubMed ID: 9803467
[TBL] [Abstract][Full Text] [Related]
4. New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).
Tjokroprawiro A
Acta Med Indones; 2006; 38(3):160-6. PubMed ID: 17119268
[TBL] [Abstract][Full Text] [Related]
5. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome.
Wajchenberg BL; Giannella-Neto D; da Silva ME; Santos RF
Horm Metab Res; 2002; 34(11-12):616-21. PubMed ID: 12660870
[TBL] [Abstract][Full Text] [Related]
6. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
7. Glitazones: clinical effects and molecular mechanisms.
Stumvoll M; Häring HU
Ann Med; 2002; 34(3):217-24. PubMed ID: 12173692
[TBL] [Abstract][Full Text] [Related]
8. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
Okuno A; Tamemoto H; Tobe K; Ueki K; Mori Y; Iwamoto K; Umesono K; Akanuma Y; Fujiwara T; Horikoshi H; Yazaki Y; Kadowaki T
J Clin Invest; 1998 Mar; 101(6):1354-61. PubMed ID: 9502777
[TBL] [Abstract][Full Text] [Related]
9. The effect of PPARgamma ligands on the adipose tissue in insulin resistance.
Hammarstedt A; Andersson CX; Rotter Sopasakis V; Smith U
Prostaglandins Leukot Essent Fatty Acids; 2005 Jul; 73(1):65-75. PubMed ID: 15936183
[TBL] [Abstract][Full Text] [Related]
10. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM
Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299
[TBL] [Abstract][Full Text] [Related]
11. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
Liu LF; Purushotham A; Wendel AA; Belury MA
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
[TBL] [Abstract][Full Text] [Related]
12. Central role of the adipocyte in the insulin-sensitising and cardiovascular risk modifying actions of the thiazolidinediones.
Smith SA
Biochimie; 2003 Dec; 85(12):1219-30. PubMed ID: 14739074
[TBL] [Abstract][Full Text] [Related]
13. Effects of rosiglitazone on gene expression in subcutaneous adipose tissue in highly active antiretroviral therapy-associated lipodystrophy.
Sutinen J; Kannisto K; Korsheninnikova E; Fisher RM; Ehrenborg E; Nyman T; Virkamäki A; Funahashi T; Matsuzawa Y; Vidal H; Hamsten A; Yki-Järvinen H
Am J Physiol Endocrinol Metab; 2004 Jun; 286(6):E941-9. PubMed ID: 14749206
[TBL] [Abstract][Full Text] [Related]
14. Abdominal adipose tissue cytokine gene expression: relationship to obesity and metabolic risk factors.
You T; Yang R; Lyles MF; Gong D; Nicklas BJ
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E741-7. PubMed ID: 15562250
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
16. Worsening of obesity and metabolic status yields similar molecular adaptations in human subcutaneous and visceral adipose tissue: decreased metabolism and increased immune response.
Klimcáková E; Roussel B; Márquez-Quiñones A; Kovácová Z; Kováciková M; Combes M; Siklová-Vítková M; Hejnová J; Srámková P; Bouloumié A; Viguerie N; Stich V; Langin D
J Clin Endocrinol Metab; 2011 Jan; 96(1):E73-82. PubMed ID: 21047918
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.
Memon RA; Tecott LH; Nonogaki K; Beigneux A; Moser AH; Grunfeld C; Feingold KR
Endocrinology; 2000 Nov; 141(11):4021-31. PubMed ID: 11089532
[TBL] [Abstract][Full Text] [Related]
18. Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss.
Milan G; Granzotto M; Scarda A; Calcagno A; Pagano C; Federspil G; Vettor R
Obes Res; 2002 Nov; 10(11):1095-103. PubMed ID: 12429872
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone: mechanism of action.
Smith U
Int J Clin Pract Suppl; 2001 Sep; (121):13-8. PubMed ID: 11594239
[TBL] [Abstract][Full Text] [Related]
20. From obesity to diabetes.
Keller U
Int J Vitam Nutr Res; 2006 Jul; 76(4):172-7. PubMed ID: 17243079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]